carefirst glp 1 coverage 🚨 Important update for patients & providers 🚨, has announced a new policy stating that GLP-1 medications will not be covered unless prescribed by a Noom-affiliated provider. This has raised CMS Issues Coverage Guidance on

11.8% average weight loss as monotherapy in Phase 3 trialsclinically significant and comparable to first-generation GLP-1 medications

[DOI] [PubMed] [Google Scholar] 13.Chen T.-H., Hu E.-H., Chen D.-Y., Lin Y., Chou T.-S., Lin M.-S., Yang N.-I., Wang C.-Y., Hung M.-J., Tsai M.-L

The evidence reveals significant heterogeneity in the effects of GLP-1RAs across different cancer types

Heres how it performed since: So, while the longs still did continue to manage going up more than the shorts, the total return of the basket was much less than the S&P500 (which I benchmark long/short to, even though prevailing wisdom is to benchmark it to T-Bills)

For context, cash-pay patients in the US could pay $499 monthly, compared with $99 a month elsewhere

Farr et al